Accelerate Resources (ASX:AX8) Announces A$1.35M Capital Raising
Accelerate Resources (ASX:AX8) secures A$1.35M to advance its gold strategy and exploration activities.
Tag: Corporate Strategy & Guidance
Australian Pacific Coal Limited (ASX:AQC) Releases Quarterly Activities Report
Australian Pacific Coal Limited (ASX:AQC) reports first commercial coal rail, production ramp-up, and financing achievements in Q4 2024 activities report.
Peninsula Energy Limited (ASX:PEN) Restarts Lance Uranium Production and Appoints New CEO
Peninsula Energy Limited (ASX:PEN) restarts Lance uranium production and appoints a new CEO, strengthening its position as an independent uranium producer.
Emperor Energy Limited (ASX:EMP) Releases December 2024 Quarterly Report
Emperor Energy (ASX:EMP) releases its December 2024 quarterly report, highlighting share placement and progress on the Judith-2 Well project.
Winchester Energy Limited (ASX:WEL) Quarterly Activities Report
Winchester Energy (ASX:WEL) reports stable quarterly performance, ongoing cost reductions, and new project reviews.
Superior Resources Limited (ASX:SPQ) Reports Significant Progress in Q4 Activities
Superior Resources Limited (ASX:SPQ) reports notable progress in exploration, including new gold zones and funding for drilling initiatives.
Aeris Environmental Ltd (ASX:AEI) Reports December 2024 Quarter Results
Aeris Environmental Ltd (ASX:AEI) reports a 5% revenue increase and outlines growth in the AerisTech Joint Venture and consumables segment.
Nova Eye Medical Limited (ASX:EYE) Completes $6.6 Million Placement
Nova Eye Medical Limited (ASX:EYE) secures $6.6 million to expand operations and enhance growth in the ophthalmic technology sector.
Aurora Energy Metals Limited (ASX:1AE) Reports December Quarter Activities
Aurora Energy Metals (ASX:1AE) reports a significant deal and advancements in uranium recovery rates for the December quarter.
Nova Eye Medical Limited (ASX:EYE) Announces Capital Raise to Drive Growth
Nova Eye Medical (ASX:EYE) announces a capital raise to bolster its financial stability and operational growth amid increasing demand in the ophthalmology sector.